Nutex Health Quarterly Cash Flow Statement
NASDAQ: NUTXConsumer DiscretionaryBusiness ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Nutex Health free cash flow
In the quarter ended Jun 30, 2026, Nutex Health generated $34.2 million of operating cash flow and spent $2.5 million on capital expenditures. That left free cash flow of $31.7 million, a free-cash-flow margin of 15.0% of revenue. Free cash flow was up 19.4% from the prior year's $26.5 million.
Nutex Health returned $19.0 million to shareholders through share repurchases, equal to 60% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Nutex Health cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 96.32M | 62.76M | 16.61M | 96.80M | 16.14M | 50.81M | 99.97M | -7.17M | 3.01M | -542.00K | -27.71M | -4.52M |
| Net Income growth (YoY) | +496.61% | +23.53% | -83.39% | — | +436.35% | — | — | — | — | — | — | — |
| Depreciation & Amortization | 5.32M | 5.49M | 5.19M | 5.00M | 5.25M | 5.09M | 5.28M | 4.97M | 4.53M | 4.19M | 4.68M | 4.75M |
| Stock-Based Compensation | — | — | 0 | 22.88M | 68.96M | 15.94M | — | — | — | — | — | — |
| Change in Working Capital | -1.62M | 4.41M | -7.94M | 1.38M | -6.42M | -54.06M | -176.66M | -7.63M | -1.45M | -3.38M | -1.87M | -2.26M |
| Operating Cash Flow | 34.20M | 75.52M | 70.39M | 99.51M | 27.26M | 50.97M | 54.00K | 6.79M | 13.26M | 3.05M | -1.78M | 1.97M |
| Capital Expenditures | -2.54M | -1.20M | -1.41M | -302.00K | -751.00K | -64.00K | -395.00K | -617.00K | -559.00K | -733.00K | 825.65K | -2.88M |
| Investing Cash Flow | -2.54M | -1.20M | -5.07M | -302.00K | 196.00K | -64.00K | -3.34M | -267.00K | -1.27M | -733.00K | 865.48K | -3.62M |
| Share Repurchases | -18.96M | -31.73M | — | — | 0 | 0 | — | — | — | — | — | — |
| Debt Issued | — | — | — | — | — | 157.00K | — | — | — | 2.92M | — | — |
| Debt Repaid | — | — | — | — | — | -1.81M | -2.70M | -483.67K | -472.02K | -4.39M | -780.60K | -833.41K |
| Financing Cash Flow | -35.19M | -49.55M | -45.79M | -29.90M | -15.45M | -6.81M | -2.99M | -421.00K | -1.19M | 5.69M | -3.91M | -4.28M |
| Net Change in Cash | -3.53M | 24.77M | 19.53M | 69.31M | 12.00M | 44.09M | -6.27M | 6.10M | 10.80M | 8.00M | -4.82M | -5.93M |
| Free Cash Flow | 31.66M | 74.32M | 68.98M | 99.21M | 26.51M | 50.90M | -341.00K | 6.17M | 12.70M | 2.32M | -950.01K | -907.25K |
This table shows 12 quarterly periods of Nutex Health's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow NUTX's reporting calendar. What is a cash flow statement?